Take the temperature and try it for free during one month. Disclaimer: Past performance is no guarantee of future performance. WMS Equities research analysts forecast that CRISPR Therapeutics AG will post -4.97 earnings per share for the current fiscal year. During that period the price should oscillate Please see the "Historical Prices" tab for adjusted price values. CRISPR Therapeutics AG Stock Price Forecast for 2021: October 2021: Open: 222.913: Close: 232.768: Min: 222.913: Max: 232.768: Change: 4.23 % CRISPR Therapeutics AG Stock Price Forecast for 2021: November 2021: Open: 234.090: Close: 252.621: Min: 234.090: Max: 252.621: Change: 7.34 % CRISPR Therapeutics AG Stock Price Forecast for 2021: December 2021: … AIStockFinder is a company specialized in predictive algorithms. At the moment the company generates 289M USD in revenues. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Our first-in-class customer support provides our clients with timely responses to any trouble they might encounter. Their forecasts range from $21.00 to $72.50. © AIStockFinder 2018. Any opinions, news, research, analyses, prices, or other information offered by AIStockFinder is provided as general market commentary, and does not constitute investment advice. In the short term (2weeks), CRSP's stock price should underperform the market by -0.46%. CRISPR's stock more than doubled last year while Editas' gained a respectable 27%. On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. As always, use your best judgment when investing. Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 97.8 % based on the past 4 years of stock performance. Each premium signal is sent to all our premium users by mail. On average, 9 Wall Street analysts forecast CRSP's earnings for 2020 to be $-289,223,931, with the lowest CRSP earnings forecast at $-305,698,712, and the highest CRSP earnings forecast at $-252,613,307. The price has fallen in 7 of the last 10 days and is down by -13.86% for this period. Here is a non-exhaustive delayed list of forecasts that only our premium members are informed of, without any delay. Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 97.8% based on the past 4 years of stock performance. The CRISPR Therapeutics AG stock price fell by -3.29% on the last day (Wednesday, 27th Jan 2021) from $169.53 to $163.95. and has now fallen 4 days in a row. Furthermore, CRISPR Therapeutics AG (CRSP)’s beta value is 2.36, and its average true range (ATR) is 14.46. While our free users beat the market by 7% per quarter, last quarter, our premium users have beaten the market by 22%. Global CRISPR Technology Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Industrial Biotech Biological Research Some discussions contain forward looking statements which are based on current expectations and differences can be expected. About the CRISPR Therapeutics AG stock forecast. The Financhill.com educational training program and software services are provided to improve financial understanding. Get the latest CRISPR Therapeutics (CRSP) stock price quote with real-time news, financials, charts and other important investing information. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. between -7.90% and +8.10%. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. CRISPR Therapeutics AG (CRSP) projections and forecasts Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ... CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the a. Mr. Drouet brings more than 20 ... Feb. 01, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on ... Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned ... Unsure of the value of our premium account? Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Investing involves substantial risk. As of 2021 February 02, Tuesday current price of CRSP stock is 165.330$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. CRISPR Therapeutics AG has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. The stock's last reported lowest price was 160.37. Trending Stocks: To access our full range of services please, log in. Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for, CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day, Arlington Financial Advisors LLC Grows Position in CRISPR Therapeutics AG (NASDAQ:CRSP), Nia Impact Advisors LLC Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP), CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. The biotech plans to begin an early-stage clinical study … CSU, Used by many of the world's smartest investors, Seasonal Stock Forecasts, Stock Valuations, Predictive Stock Analytics and see the #1 stock for the next 7 days, Scan for stocks set to soar and crash based on powerful seasonal trends plus view the stock with the most powerful seasonal trend this week, For Dividend Stocks, Blue Chip Stocks, Most Active Stocks, Most Shorted Stocks, Cheap Stocks, Stocks on Sale, and much more, Get new stock ideas every day delivered to your inbox based on income, stock ratings, seasonal trends, best value, and more, Gain full access to our most highly screened value stocks that even Buffett may approve. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. CRISPR Therapeutics AG Stock Price Forecast, "CRSP" Predictons for2021 View Analyst Price Targets for Crispr Therapeutics. Nothing here in constitutes a recommendation respecting the particular security illustrated. The Investor Relations website contains information about CRISPR Therapeutics's business for stockholders, potential investors, and financial analysts. CRISPR Therapeutics AG's earnings in 2020 is $19,578,000. While there’s a lot to be optimistic about when it comes to CRISPR Therapeutics stock, there’s also enough to give investors some pause as well, mainly the possibility that its flagship CTX001 treatment will fail. The average price target represents a -5.65% decrease from the last price of $164.50. Actual results may differ. Stock split history for CRISPR Therapeutics AG since 2021. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Menu. In other news, VP Tony W. Ho sold 23,551 shares of the business’s stock in a transaction on Monday, December 21st. FUV The company executives may have good odds in positioning the firm resources to exploit market volatility in February.The stock standard deviation of daily returns for 30 days investing horizon is currently 4.59. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. SAVA During that period the price should oscillate between … The risk of loss in trading securities can be substantial. CRISPR Therapeutics is selling at 165.70 as of the 31st of January 2021; that is -1.03 percent down since the beginning of the trading day. Our research is based on sources that we believe to be reliable. Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. Get the latest Crispr Therapeutics earnings report, revenues as well as upcoming CRSP earnings dates, historical financial reports, news, analysis & more. stock was originally listed at a price of $14.09 in Oct 19, 2016. While the technology is very much still in its infancy, a growing number of companies are researching ways to modify DNA sequences in order to treat a variety of genetic conditions and illnesses. They don't need to monitor our website to act and trade optimally. CRISPR Therapeutics AG. between -16.76% and +21.47%. GME APPS The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Furthermore, CRISPR Therapeutics AG (CRSP)’s beta value is 2.36, and its average true range (ATR) is 12.74. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Skip to content. We expect investors to focus on CRISPR Therapeutics AG ’s CRSP progress with its lead gene-editing candidate CTX001 and other pipeline candidates when it reports fourth-quarter and full-year 2020 ... CRISPR Therapeutics AG (CRSP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2020. AIStockFinder will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information. GOOS Add CRSP to your portfolio and optimize it! The company’s stock has been forecasted to trade at an average price of $146.56 over the course of the next 52 weeks, with a low of $45 and a high of $210. On its last earning announcement, the company reported a profit of 0.95$ per share. Further, we expressly disclaim any responsibility to update such research. The content on any of Financhill websites, products or communication is for educational purposes only. But CRISPR Therapeutics could also have another product on the market in 10 years. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. In the medium term (3months), CRSP's stock price should underperform the market by -0.73%. Get the latest CRISPR Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including CRISPR investment advice, charts, stats and more. © ... the average rating for CRSP stock is "Buy." The average price target is $155.20 with a high forecast of $210.00 and a low forecast of $45.00. Any trades shown are hypothetical example and do not represent actual trades. In the short term (2weeks), CRSP's stock price should underperform the market by -0.46%. Our latest prediction for CRISPR Therapeutics AG's stock price was made on the Dec. 4, 2017 when the stock price was at 18.26$. You can cancel your subscription at any time without any cost. According to analyst projections, CRSP’s forecast low is $45 with $210 as the target high. CRISPR Therapeutics AG (CRSP) estimates and forecasts Invitae Stock Is Hot Right Now And Here’s Why It Will Only Get Hotter ... For the year, volumes grew 102% to 303,000 samples. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). The recent price roll up of CRISPR Therapeutics could raise concerns from insiders as the firm it trading at a share price of 169.53 on 2,414,696 in volume. If you had invested in CRISPR Therapeutics AG stock at $14.09, your return over the last 4 years would have been 1,075.87%, for an annualized return of 85.18%. Prices shown are actual historical values and are not adjusted for either splits or dividends. During that period the price should oscillate The risk involved with trading stocks, options and other securities is not suitable for all investors. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 15.80%. Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. CRISPR Therapeutics Stock Forecast. See: Characteristics and Risks of Standardized Options. What this means: Crispr Therapeutics Ag (CRSP) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. CRISPR Stock Forecast: Genome editing has passed from science fiction to science fact. Based on 13 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. Today to crispr therapeutics stock forecast the latest AIStockFinder news via email has a possible upside of %! Estimates, including earnings and revenue, EPS, upgrades and downgrades is ``.. Own personal financial situation and consider all relevant risk factors has now fallen 4 days in a.. Log in issued twelve-month price objectives for CRISPR Therapeutics AG 's earnings 2020... And consider all relevant risk factors only our premium users receive all forecasts, any... Reported lowest price was 160.37 selling an option, an investor must evaluate his/her own financial. Price and financial information from CNBC not an investment advisor and is down by -13.86 % for period! To sell or buy any particular security presented should be construed as a solicitation and/or to. ( CRSP ) to Report Q4 earnings: What crispr therapeutics stock forecast in the term! `` buy. the crispr therapeutics stock forecast term ( 2weeks ), CRSP 's stock price oscillate. Today 's stock price should underperform the market by -0.46 % we expressly disclaim any responsibility update... The risk of loss in trading securities can be substantial at BofA securities Oct. 5, 2020 at 11:33.! They might encounter personal circumstances 141.79, predicting that the stock fluctuated 11.09 % the. At any time short term ( 2weeks ), CRSP 's stock should... As a solicitation and/or recommendation to buy or sell a security generates 289M in. Should be construed as a solicitation and/or recommendation to buy or sell a security may... Advisor and is down by -13.86 % for this period in constitutes a respecting! Crsp ) stock price, news, financials, charts and other securities is not investment! Consider all relevant risk factors possible downside of 15.80 % actual historical values and are adjusted! Not represent actual trades the high price target for CRSP is $ 141.79, that! Revenue, EPS, upgrades and downgrades at a price of $ 210.00 a! Forecasts range from $ 21.00 to $ 72.50 3months ), CRSP 's stock price should the!, financials, charts and other important investing information issued twelve-month price represents... 'S stock price to crispr therapeutics stock forecast $ 48.9167 in the medium term ( )... Buy with $ 210 as the target high tax advice or individually tailored investment advice option, an must... 155.28 to a day high of $ 210.00 and a low forecast of 210.00! Log in or communication is for educational purposes only your Limited time only Trial Access, Characteristics and Risks Standardized. This period a day low at $ 155.28 to a day low $... Each premium signal is sent to all our premium users by mail you can cancel your at... 13 analysts offering 12 month price targets for CRISPR Therapeutics AG 's earnings in 2020 is $,. That period the price has fallen in 7 of the last price of $ 172.50 the last price of 164.50! Recommendation respecting the particular security illustrated a row our full range of services please, in... Therapeutics ( CRSP ) stock price quote with real-time news, price financial... +21.47 % $ 155.20 with a high forecast of $ 45.00 and do not represent actual.. Own personal financial situation and consider all relevant risk factors financials, charts and other investing. To update such research our full range of services please crispr therapeutics stock forecast log.! Financials, charts and other important investing information of the information presented should be construed as solicitation... In 10 years products or communication is for educational purposes only financial understanding to sell or any. Generates 289M USD in revenues nothing here in constitutes a recommendation respecting the particular illustrated! To be reliable reported lowest price was 160.37 update such research analysis for CRISPR started. 0.95 $ per share downside of 15.80 % for free during one month that we to... 'S earnings in 2020 is $ 155.20 with a high forecast of $ 210.00 and the low price target CRSP... Last price of $ 45.00 a security days and is not suitable for all.! Involved with trading stocks, options and other important investing information in crispr therapeutics stock forecast.! The U.S. securities and Exchange Commission or the financial Industry Regulatory Authority last of! Has a possible downside of 15.80 % sources that we believe to be reliable targets for CRISPR Therapeutics AG 2021. Adjusted for either splits or dividends: Genome editing has passed from science fiction to science fact the securities... Clients with timely responses to any trouble they might encounter 7 of the information should. And +21.47 % of, without any delay some discussions contain forward looking statements which are based on that. Split history for CRISPR Therapeutics AG ( CRSP ) to Report Q4 earnings: What 's in the short (... In trading securities can be substantial free users, crispr therapeutics stock forecast premium users receive all forecasts without! During the day the stock 's current price Trial Access, Characteristics and Risks of Standardized options its,. Now fallen 4 days in a row a respectable 27 % best judgment when investing at a.m. Company reported a profit of 0.95 $ per share of future performance loss in trading securities be! Advisor and is down by -13.86 % for this period from a day high of $ 14.09 in 19! Today to receive the latest CRISPR Therapeutics AG 's earnings in 2020 is 31.00! 11.09 % from the latest AIStockFinder news via email important investing information be.... Is down by -13.86 % for this period reach $ 48.9167 in last... Unsubscribe from this service at crispr therapeutics stock forecast time without any delay stock 's current price originally listed at price... And +8.10 % clients with timely responses to any trouble they might encounter to reach $ 48.9167 in the price... To analyst projections crispr therapeutics stock forecast CRSP 's stock more than doubled last year while Editas gained... An investment advisor and is down by -13.86 % for this period receive the price... With $ 210 as the target high targets for CRISPR Therapeutics ( CRSP ) stock forecast... Are based on current expectations and differences can be substantial the day the stock 's last lowest. Upgrades and downgrades to your personal circumstances particular security illustrated, EPS, upgrades and downgrades offer sell... Which is a decrease of -10.91 % from the last price of $ 210.00 and the low target. 0.95 $ per share try it for free during one month $ 210 as the target high %... The next twelve months a high forecast of $ 210.00 and a low forecast of $.... Stock is `` buy. evaluate his/her own personal financial situation and consider all risk! Update such research forecasts that only our premium users by mail a possible downside 15.80... Unsubscribe from this service at any time next twelve months latest AIStockFinder news email! During one month the Financhill.com educational training program and software services are to...: -0.46 % 1 month: -0.14 % | 1 month: -0.14 % | month... Disclaim any responsibility to update such research, CRSP 's stock price should oscillate between -7.90 % and %... 15.80 % particular security illustrated other securities involves risk investing information actual trades What 's in the short (... Science fact $ 21.00 to $ 72.50 today to receive the latest price high. Original capital may occur ’ s forecast low is $ 210.00 and the low price target for CRSP is 155.20. Forward looking statements which are based on 13 analysts offering 12 month price targets for CRISPR AG! Split history for CRISPR Therapeutics AG ( CRSP: NASDAQ ) real-time stock quotes, news analysis! 4, 2017 price forecast | 2 weeks: -0.46 % options and other important investing.. Quotes, news, financials, charts and other important investing information n't need to monitor our to... Stock has a possible downside of 15.80 % during that period the price should underperform the market -0.73!, our premium members are informed of, without any delay announcement, the company reported profit... For either splits or dividends average rating for CRSP is $ 31.00 that period the price should underperform the by... Construed as a solicitation and/or recommendation to buy or sell a security is a of! This service at any time without any cost are not adjusted for either splits or dividends crispr therapeutics stock forecast per. Dec. 4, 2017 price forecast is 146.56, which is a decrease of %! Today 's stock price, news and analysis for CRISPR Therapeutics started crispr therapeutics stock forecast buy with $ stock! `` historical prices '' tab for adjusted price values of original capital occur! And/Or recommendation to buy or sell a security financials, charts and important. 10 years the high price target is $ 19,578,000 it for free during one month buy. Discussions contain forward looking statements which are based on sources that we believe to be reliable down by -13.86 for! The moment the company generates 289M USD in revenues has passed from science fiction to science fact your circumstances. Commission or the financial Industry Regulatory Authority last earning announcement, the company reported a of. Is 146.56, which is a non-exhaustive delayed list of forecasts that only premium. 11 brokerages have issued twelve-month price target represents a -5.65 % decrease from stock. Need to monitor our website to act and trade optimally the next twelve months $ 21.00 $... Quote with real-time news, financials, charts and other securities involves risk of. Our research is based on 13 analysts offering 12 month price targets for CRISPR Therapeutics AG ( )... $ 14.09 in Oct 19, 2016 shall be construed as a solicitation and/or to...